69 related articles for article (PubMed ID: 18988705)
1. Analysis of the oestrogen response in an angiomyolipoma derived xenograft model.
Clements D; Asprey SL; McCulloch TA; Morris TA; Watson SA; Johnson SR
Endocr Relat Cancer; 2009 Mar; 16(1):59-72. PubMed ID: 18988705
[TBL] [Abstract][Full Text] [Related]
2. Role of the CXCR4/CXCL12 axis in lymphangioleiomyomatosis and angiomyolipoma.
Clements D; Markwick LJ; Puri N; Johnson SR
J Immunol; 2010 Aug; 185(3):1812-21. PubMed ID: 20585037
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.
Li C; Zhang E; Sun Y; Lee PS; Zhan Y; Guo Y; Osorio JC; Rosas IO; Xu KF; Kwiatkowski DJ; Yu JJ
PLoS One; 2014; 9(10):e104809. PubMed ID: 25347447
[TBL] [Abstract][Full Text] [Related]
4. The TSC-2 product tuberin is expressed in lymphangioleiomyomatosis and angiomyolipoma.
Johnson SR; Clelland CA; Ronan J; Tattersfield AE; Knox AJ
Histopathology; 2002 May; 40(5):458-63. PubMed ID: 12010366
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma-Jak-Stat signaling in pulmonary lymphangioleiomyomatosis and renal angiomyolipoma: a potential therapeutic target.
El-Hashemite N; Kwiatkowski DJ
Am J Respir Cell Mol Biol; 2005 Sep; 33(3):227-30. PubMed ID: 15994429
[TBL] [Abstract][Full Text] [Related]
6. Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways.
Yu J; Astrinidis A; Howard S; Henske EP
Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L694-700. PubMed ID: 12922981
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary lymphangioleiomyomatosis (LAM): progress and current challenges.
Goncharova EA; Krymskaya VP
J Cell Biochem; 2008 Feb; 103(2):369-82. PubMed ID: 17541983
[TBL] [Abstract][Full Text] [Related]
8. Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: epidermal growth factor is the required growth factor.
Lesma E; Grande V; Carelli S; Brancaccio D; Canevini MP; Alfano RM; Coggi G; Di Giulio AM; Gorio A
Am J Pathol; 2005 Oct; 167(4):1093-103. PubMed ID: 16192644
[TBL] [Abstract][Full Text] [Related]
9. Renal angiomyolipomas from patients with sporadic lymphangiomyomatosis contain both neoplastic and non-neoplastic vascular structures.
Karbowniczek M; Yu J; Henske EP
Am J Pathol; 2003 Feb; 162(2):491-500. PubMed ID: 12547707
[TBL] [Abstract][Full Text] [Related]
10. Estrogen enhances whereas tamoxifen retards development of Tsc mouse liver hemangioma: a tumor related to renal angiomyolipoma and pulmonary lymphangioleiomyomatosis.
El-Hashemite N; Walker V; Kwiatkowski DJ
Cancer Res; 2005 Mar; 65(6):2474-81. PubMed ID: 15781664
[TBL] [Abstract][Full Text] [Related]
11. Development of a lymphangioleiomyomatosis model by endonasal administration of human TSC2-/- smooth muscle cells in mice.
Lesma E; Eloisa C; Isaia E; Grande V; Ancona S; Orpianesi E; Di Giulio AM; Gorio A
Am J Pathol; 2012 Sep; 181(3):947-60. PubMed ID: 22770663
[TBL] [Abstract][Full Text] [Related]
12. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
13. Metastasis of benign tumor cells in tuberous sclerosis complex.
Henske EP
Genes Chromosomes Cancer; 2003 Dec; 38(4):376-81. PubMed ID: 14566858
[TBL] [Abstract][Full Text] [Related]
14. Lymphangioleiomyomatosis: A Monogenic Model of Malignancy.
Krymskaya VP; McCormack FX
Annu Rev Med; 2017 Jan; 68():69-83. PubMed ID: 28099079
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
[TBL] [Abstract][Full Text] [Related]
16. Natural history of angiomyolipoma in lymphangioleiomyomatosis: implications for screening and surveillance.
Yeoh ZW; Navaratnam V; Bhatt R; McCafferty I; Hubbard RB; Johnson SR
Orphanet J Rare Dis; 2014 Oct; 9():151. PubMed ID: 25277108
[TBL] [Abstract][Full Text] [Related]
17. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells.
Potiron VA; Sharma G; Nasarre P; Clarhaut JA; Augustin HG; Gemmill RM; Roche J; Drabkin HA
Cancer Res; 2007 Sep; 67(18):8708-15. PubMed ID: 17875711
[TBL] [Abstract][Full Text] [Related]
18. Anti-EGFR antibody efficiently and specifically inhibits human TSC2-/- smooth muscle cell proliferation. Possible treatment options for TSC and LAM.
Lesma E; Grande V; Ancona S; Carelli S; Di Giulio AM; Gorio A
PLoS One; 2008; 3(10):e3558. PubMed ID: 18958173
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.
Sato T; Seyama K; Fujii H; Maruyama H; Setoguchi Y; Iwakami S; Fukuchi Y; Hino O
J Hum Genet; 2002; 47(1):20-8. PubMed ID: 11829138
[TBL] [Abstract][Full Text] [Related]
20. β-Catenin is a useful adjunct immunohistochemical marker for the diagnosis of pulmonary lymphangioleiomyomatosis.
Flavin RJ; Cook J; Fiorentino M; Bailey D; Brown M; Loda MF
Am J Clin Pathol; 2011 May; 135(5):776-82. PubMed ID: 21502434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
